Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Influenza HA Vaccine in Healthy Elderly Adults
NCT00170443Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rHAO Trivalent Influenza Vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
rHAO Trivalent Influenza Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00170443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170443.